Selected Publications

Academic Article

Year Title Altmetric
2020 Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple SclerosisAnnals of Neurology.  88:42-55. 2020
2019 miRNA contributions to pediatric-onset multiple sclerosis inferred from GWASAnnals of Clinical and Translational Neurology.  6:1053-1061. 2019
2019 Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple SclerosisJournal of Child Neurology.  34:148-152. 2019
2019 Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestryPLoS Genetics.  15. 2019
2019 Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline 2019
2019 Vitamin D genes influence MS relapses in children 2019
2018 Genetic risk factors for pediatric-onset multiple sclerosis 2018
2018 Several household chemical exposures are associated with pediatric-onset multiple sclerosisAnnals of Clinical and Translational Neurology.  5:1513-1521. 2018
2018 Heterogeneity in association of remote herpesvirus infections and pediatric MSAnnals of Clinical and Translational Neurology.  5:1222-1228. 2018
2018 Urban air quality and associations with pediatric multiple sclerosisAnnals of Clinical and Translational Neurology.  5:1146-1153. 2018
2018 Dietary factors and pediatric multiple sclerosis: A case-control study 2018
2018 Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosisMultiple Sclerosis and Related Disorders.  22:103-107. 2018
2018 Correction to: Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial (Quality of Life Research, (2017), 26, 9, (2333-2349), 10.1007/s11136-017-1571-z)Quality of Life Research.  27:1117. 2018
2018 Contribution of dietary intake to relapse rate in early paediatric multiple sclerosisJournal of Neurology, Neurosurgery and Psychiatry.  89:28-33. 2018
2018 Pediatric multiple sclerosis: current perspectives on health behaviors.Pediatric Health, Medicine and Therapeutics.  9:17-25. 2018
2017 Examining the contributions of environmental quality to pediatric multiple sclerosisMultiple Sclerosis and Related Disorders.  18:164-169. 2017
2017 Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trialQuality of Life Research.  26:2333-2349. 2017
2017 Evidence for a causal relationship between low Vitamin D, high BMI, and pediatric-onset MSNeurology.  88:1623-1629. 2017
2017 Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric populationJournal of the Neurological Sciences.  375:371-375. 2017
2017 Maternal and perinatal exposures are associated with risk for pediatric-onset multiple sclerosisPediatrics.  139. 2017
2016 Dietary salt intake and time to relapse in paediatric multiple sclerosisJournal of Neurology, Neurosurgery and Psychiatry.  87:1350-1353. 2016
2016 Distinct effects of obesity and puberty on risk and age at onset of pediatric MSAnnals of Clinical and Translational Neurology.  3:897-907. 2016
2016 Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controlsBMC Neurology.  16. 2016
2016 Pediatric multiple sclerosis Clinical features and outcomeNeurology.  87:S74-S81. 2016
2016 T cell cytokine signatures: Biomarkers in pediatric multiple sclerosisJournal of Neuroimmunology.  297:1-8. 2016
2016 Gut microbiota in early pediatric multiple sclerosis: a case‚ąícontrol studyEuropean Journal of Neurology.  23:1308-1321. 2016
2016 Characteristics of children and adolescents with multiple sclerosisPediatrics.  138. 2016
2016 Gut microbiota composition and relapse risk in pediatric MS: A pilot studyJournal of the Neurological Sciences.  363:153-157. 2016
2016 A case-control study of dietary salt intake in pediatric-onset multiple sclerosisMultiple Sclerosis and Related Disorders.  6:87-92. 2016
2016 Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers reportNeurology.  86:245-252. 2016
2015 CSF and blood levels of GFAP in Alexander diseaseeNeuro.  2. 2015
2015 Prolonged Remission in Neuromyelitis Optica Following Cessation of Rituximab TreatmentJournal of Child Neurology.  30:1366-1370. 2015
2015 The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next StepsJournal of Child Neurology.  30:1381-1387. 2015
2014 Protective environmental factors for neuromyelitis opticaNeurology.  83:1923-1929. 2014
2014 Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: Report from the US Pediatric Multiple Sclerosis Network 2014
2013 Quantitative MRI analysis in children with multiple sclerosis: A multicenter feasibility pilot studyBMC Neurology.  13. 2013
2013 Seizure occurrence following nonoptimal anticonvulsant medication management during the transition into the hospitalJournal of Child Neurology.  28:1250-1258. 2013
2013 BAFF/APRIL system in pediatric OMS: Relation to severity, neuroinflammation, and immunotherapyJournal of Neuroinflammation.  10. 2013
2013 Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis 2013
2013 Cognitive impairment occurs in children and adolescents with multiple sclerosis: Results from a United States networkJournal of Child Neurology.  28:102-107. 2013
2012 Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMSJournal of Neuroimmunology.  243:81-88. 2012
2012 Examining sleep, fatigue, and daytime sleepiness in pediatric multiple sclerosis patients 2012
2011 Common viruses associated with lower pediatric multiple sclerosis riskNeurology.  76:1989-1995. 2011
2011 Management of pediatric central nervous system demyelinating disorders: Consensus of United States neurologistsJournal of Child Neurology.  26:675-682. 2011
2011 Pediatric Multiple SclerosisNeurologic Clinics.  29:481-505. 2011
2011 Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosisArchives of Neurology.  68:437-444. 2011
2010 Neurocognitive sequelae in African American and Caucasian children with multiple sclerosisNeurology.  75:2097-2102. 2010
2010 Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosisJournal of Neuroimmunology.  223:92-99. 2010
2010 Prophylactic phenobarbital and whole-body cooling for neonatal hypoxic-ischemic encephalopathyJournal of Pediatrics.  157:334-336. 2010
2010 Treatment of multiple sclerosis in children and adolescentsExpert Opinion on Pharmacotherapy.  11:505-520. 2010
2010 Younger children with MS have a distinct CSF inflammatory profile at disease onsetNeurology.  74:399-405. 2010
2009 Pediatric multiple sclerosisNature Reviews Neurology.  5:621-631. 2009
2009 Age-Dependent B Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple SclerosisJournal of Immunology.  183:4067-4076. 2009
2009 Hepatitis vaccines and pediatric multiple sclerosis: Does timing or type matter?Neurology.  72:870-871. 2009
2008 Intravenous thrombolysis followed by intra-arterial thrombolysis and mechanical thrombectomy for the treatment of pediatric ischemic strokeJournal of the Neurological Sciences.  275:151-153. 2008
2008 CNS aquaporin-4 autoimmunity in childrenNeurology.  71:93-100. 2008
2008 Adult T-cell leukemia/lymphoma in an adolescent presenting with skin lesionsPediatric Dermatology.  25:373-377. 2008
2008 Differential activation of c-Fos and caspase-3 in hippocampal neuron subpopulations following neonatal hypoxia-ischemiaJournal of Neuroscience Research.  86:1115-1124. 2008
2007 Clinical features and viral serologies in children with multiple sclerosis: a multinational observational studyLancet Neurology.  6:773-781. 2007
2007 Acute disseminated encephalomyelitisNeurology.  68. 2007
2007 Clinical features of children and adolescents with multiple sclerosisNeurology.  68. 2007
2007 MRI features of pediatric multiple sclerosisNeurology.  68. 2007
2006 Selective involvement of BH3-only Bcl-2 family members Bim and Bad in neonatal hypoxia-ischemiaBrain Research.  1099:150-159. 2006
2004 Bcl-2 family regulation of neuronal development and neurodegeneration 2004
2003 Combined tyramide signal amplification and quantum dots for sensitive and photostable immunofluorescence detection 2003
1995 Stimulation of rat granulosa cell progesterone production but not other differentiated functions by a splenocyte-derived factor 1995
1994 Induction of rat granulosa cell steroidogenic enzyme activities and their messenger ribonucleic acids by a splenocyte-derived factorMolecular and Cellular Endocrinology.  106:163-170. 1994
1992 Gonadotropin regulation of c-fos and c-jun messenger ribonucleic acids in cultured rat granulosa cellsMolecular and Cellular Endocrinology.  90:17-25. 1992
1991 Specific identification and subcellular localization of three calmodulin-binding proteins in the rat gonadotrope: Spectrin, caldesmon, and calcineurinBiology of Reproduction.  44:43-52. 1991
1988 The Ca2+-dependent protease inhibitor of rat ventral prostate: properties of the inhibitor and effects of castration on Ca2+-dependent protease and inhibitor activities 1988


Year Title Altmetric
2011 Symptomatic therapy in pediatric multiple sclerosis.  112-133. 2011

Principal Investigator On

  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2013 - 2023
  • Private Grant  awarded by CHUGAI PHARMACEUTICAL COMPANY LTD 2015 - 2021
  • 2019 CPODD Family Retreat  awarded by Multiple Sclerosis Foundation 2020
  • Diet and Relapse Risk in Pediatric Multiple Sclerosis  awarded by University of California, San Francisco 2017 - 2020
  • Pediatric MS Network  awarded by University of Utah 2019 - 2020
  • Private Grant  awarded by Genentech 2019 - 2020
  • Patient-family Views on Pediatric MS Research, Needs, Outcomes, and Methods  awarded by MASSACHUSETTS GENERAL HOSPITAL 2018 - 2019
  • Pediatric Data Coordinating and Analysis Center  awarded by University of Utah 2016 - 2019
  • Environmental & Genetic Risk Factors in Pediatric MS  awarded by University of California, San Francisco 2017 - 2018
  • Microbiomes in Pediatric Multiple Sclerosis  awarded by University of California 2013 - 2018
  • Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis  awarded by University of California, San Francisco 2011 - 2017
  • Treatment Adherence in Pediatric Multiple Sclerosis: Project 5982896  awarded by HOSPITAL FOR SICK CHILDREN 2014 - 2016
  • Pediatric Data Coordinating and Analysis Center  awarded by University of Utah 2012 - 2016
  • Clinical and MRI Features of NMO Spectrum Disorders in Children  awarded by MASSACHUSETTS GENERAL HOSPITAL 2012 - 2013
  • Center for Pediatric-Onset Demyelinating Disease  awarded by National Multiple Sclerosis Society 2006 - 2013
  • Private Grant  awarded by EMD SERONO 2010 - 2012
  • Education And Training

  • Doctor of Medicine, University of Iowa 1995
  • Doctor of Philosophy, University of Iowa 1995
  • UAB Hospital, Internship 1996
  • UAB Hospital, Residency 1998
  • UAB Hospital, Postdoctoral Fellowship 2001
  • Full Name

  • Jayne Ness